Christopher M. Adams

Christopher M. Adams, M.D., Ph.D., is a Professor of Medicine and Research Chair at the Mayo Clinic in Rochester, Minnesota. He is a board-certified endocrinologist and physician scientist with expertise in skeletal muscle biology, diabetes, obesity, and aging.

• Founder and CEO of Emmyon, Inc., developing skeletal muscle therapeutics
• Lead inventor on 30+ patents for small molecules targeting muscle atrophy
• Active in Mayo Clinic's Endocrinology, Diabetes, Metabolism, and Nutrition division

Education Highlights:

• M.D./Ph.D. in Physiology and Biophysics, University of Iowa
• Fellowship in Endocrinology, University of Texas Southwestern
• BS in Cellular Biology, University of Kansas

His research focuses on skeletal muscle atrophy mechanisms, particularly through the ATF4 pathway, and developing interventions for muscle wasting and metabolic diseases. Key trends in his 2024-2025 articles include phosphoproteome acetylation, aging-induced lncRNA regulation, and ATF4's role in adipocyte thermogenesis.

Scientific Awards:

• George M. and Edna B. Endicott Professor of Medicine (2025)
• Senior Clinical Scientist Award, U.S. Department of Veterans Affairs (2019)
• Clinical Scientist Development Award, Doris Duke Charitable Foundation (2009)
• Medical Scientist Training Program (MSTP) Fellowship (1992)

Dr. Adams holds leadership roles in national programs like the Skeletal Muscle Atrophy Rehabilitation and Therapeutics (SMART) initiative and collaborates on global research projects. His work extends to biotechnology entrepreneurship and translational science.